Home / Healthcare / Pharmaceutical / U.S. Inflammatory Bowel Disease Treatment Market

U.S. Inflammatory Bowel Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Disease Indication (Ulcerative Colitis and Crohns Disease), By Route of Administration (Oral and Injectables), By Drug Class (IL Inhibitors, TNF Inhibitors, Anti-integrin, JAK Inhibitors, Corticosteroids, ASA Drugs, and Others), By Distribution Channel (Hospital Pharmacy and Retail Pharmacy & Other), and Country Forecast, 2023-2030

Report Format: PDF | Latest Update: Sep, 2024 | Published Date: Dec, 2023 | Report ID: FBI108774 | Status : Published
  • 2022
  • 80
  • PRICE
  • $ 2850
    $ 3850
    $ 4850
    Buy Now

Healthcare Clients